Financial comparisons BeiGene, Ltd.

Equities

BGNE

US07725L1026

Biotechnology & Medical Research

Market Closed - Nasdaq 01:30:00 14/09/2024 am IST 5-day change 1st Jan Change
198.49 USD +1.13% Intraday chart for BeiGene, Ltd. +3.75% +10.05%
Main competitors
Add to a list
Revenues ($) (Y-1) Net margin (Y-1) Operating Margin (Y-1) ROE (Y-1) ROA (Y-1) Leverage (Debt/EBITDA) (Y-1)
245.88Cr -35.86%-49.12%-22.26%-14.47%2.05x
986.92Cr +36.68%+44.33%+22.99%+17.71%-2.46x
1.31TCr +30.14%+39.08%+20.74%+16.20%-1.6x
129.83Cr -23.26%-33.51%-8.54%-7.69%10.14x
423.44Cr +24.36%+18.08%+4.62%+4.02%-13.1x
244.76Cr +26.42%+32.30%+14.78%+13.31%-5.01x
568.57Cr +26.50%+29.43%+18.99%+15.45%-0.64x
31Cr -245.59%-232.51% - -50.20%-0.8x
188.71Cr +13.23%+13.30%+12.68%+8.89%-5.76x
124.33Cr -43.11%-21.54%-86.15%-1.86%1.96x
5.09Cr -205.30%-166.94%-58.43% - 2.98x
29Cr -181.75%-144.69%-51.94%-32.60%2.5x
83Cr +33.96%+40.71%+293.15%+20.80%2.73x
183.02Cr +11.35%+9.34%+8.74%+6.91%-5.06x
16Cr -12.22%-37.48%-3.46%-2.93%11.91x
64Cr +44.81%+45.26%+55.36%+27.64%0.65x
Average 289.63Cr -31.23% -25.87% +14.75% +1.41% 0.03x
Weighted average by Cap. 729.98Cr +4.09% +9.46% +14.22% +8.61% -1.22x
Bio Therapeutic Drugs
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW